Skip to main navigation Skip to search Skip to main content

Strategies for multivessel revascularization in patients with diabetes

  • Michael E Farkouh
  • , Michael Domanski
  • , Lynn A Sleeper
  • , Flora S Siami
  • , George Dangas
  • , Michael Mack
  • , May Yang
  • , David J Cohen
  • , Yves Rosenberg
  • , Scott D Solomon
  • , Akshay S Desai
  • , Bernard J Gersh
  • , Elizabeth A Magnuson
  • , Alexandra Lansky
  • , Robin Boineau
  • , Jesse Weinberger
  • , Krishnan Ramanathan
  • , J Eduardo Sousa
  • , Jamie Rankin
  • , Balram Bhargava
  • John Buse, Whady Hueb, Craig R Smith, Victoria Muratov, Sameer Bansilal, Spencer King, Michel Bertrand, Valentin Fuster, FREEDOM Trial Investigators, Timothy Lyons

Research output: Contribution to journalArticlepeer-review

Abstract

In some randomized trials comparing revascularization strategies for patients with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than percutaneous coronary intervention (PCI). We sought to discover whether aggressive medical therapy and the use of drug-eluting stents could alter the revascularization approach for patients with diabetes and multivessel coronary artery disease.
Original languageEnglish
Pages (from-to)2375-84
Number of pages10
JournalNew England Journal of Medicine
Volume367
Issue number25
DOIs
Publication statusPublished - 20 Dec 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Aged
  • Angioplasty, Balloon, Coronary
  • Cardiovascular Diseases
  • Coronary Artery Bypass
  • Coronary Artery Disease
  • Diabetes Complications
  • Drug-Eluting Stents
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Myocardial Infarction
  • Stroke

Fingerprint

Dive into the research topics of 'Strategies for multivessel revascularization in patients with diabetes'. Together they form a unique fingerprint.

Cite this